Biomarker NTproBNP in Patients with Severe CommunityAcquired Pneumonia

The aim of the study was to determine the correlation between blood levels of Nterminal portion of the inactive precursor of natriuretic peptide of Btype (NTproBNP) and hemodynamic, clinical and laboratory parameters in the course of intensive treatment of patients with severe communityacquired pneu...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Kozlov, I. N. Tyurin, S. N. Avdeykin, I. Y. Ufimtseva, A. V. Salikov, N. A. Karpun
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2016-07-01
Series:Общая реаниматология
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/1527
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850029182522753024
author I. A. Kozlov
I. N. Tyurin
S. N. Avdeykin
I. Y. Ufimtseva
A. V. Salikov
N. A. Karpun
author_facet I. A. Kozlov
I. N. Tyurin
S. N. Avdeykin
I. Y. Ufimtseva
A. V. Salikov
N. A. Karpun
author_sort I. A. Kozlov
collection DOAJ
description The aim of the study was to determine the correlation between blood levels of Nterminal portion of the inactive precursor of natriuretic peptide of Btype (NTproBNP) and hemodynamic, clinical and laboratory parameters in the course of intensive treatment of patients with severe communityacquired pneumonia (CAP).Materials and methods. The study included 12 patients (10 men and 2 women) with severe CAP, age 25—88 (51.5 (41.25; 69)) years. The severity of the condition was as follows (averages and percentiles): on a scale of CURB65 — 3—5 (4; 4,5) scores, APACHE II — 16—33 (23 (18.75; 25)) scores, SOFA — 6—16 (10 (9; 12.75)) points. Concentartions of NTproBNP in venous blood 24—36 h post admission and on day 5 of treatment were determined by analyzer Dimension Xpand Plus (Siemens).Results. Within 24—36 hours after the admission concentration of NTproBNP was 783.5 (460.75; 4150.25) pg/ml. The content of the biomarker remained higher than in norm in 66.7% of patients. By the 5th day the concentration of the biomarker was 537 (376.25, 1334) pg/ml. In surviving patients (66.7%), the concentration of NT proBNP was decreasing (P=0.008) to day 5 of treatment from 918 (560, 8501) to 391 (341, 1010) pg/ml. CAP patients who did not survived later (32.3%) exhibited no decrease of the biomarker concentration. Significant correlation between NTproBNP on admission to ISU and index of total peripheral vascular resistance on day 2 of intensive treatment (r=0.63; p<0.05) and day 5 (r=0.58, P<0.05) was revealed. Echocardiography systolic pulmonary artery pressure correlated with the content of NTproBNP 24—36 hours after admission to the Intensive Care Unit and on the 5th day of treatment.Conclusion. We suggested that the reason for increased concentration of NTproBNP is an overload of the right ventricle myocardium due to pulmonary hypertension as a characteristic of acute respiratory distress syndrome.
format Article
id doaj-art-a1ef48a5f701441789cf0cdbba7cd1bd
institution DOAJ
issn 1813-9779
2411-7110
language English
publishDate 2016-07-01
publisher Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
record_format Article
series Общая реаниматология
spelling doaj-art-a1ef48a5f701441789cf0cdbba7cd1bd2025-08-20T02:59:35ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102016-07-01123243310.15360/1813-9779-2016-3-24-331505Biomarker NTproBNP in Patients with Severe CommunityAcquired PneumoniaI. A. Kozlov0I. N. Tyurin1S. N. Avdeykin2I. Y. Ufimtseva3A. V. Salikov4N. A. Karpun5A. Negovsky Research Institute of General Reanimatology; M.F. Vladimirsky Moscow Regional Research Clinical InstituteA. Negovsky Research Institute of General Reanimatology; V. M. Buyanov State clinical hospital, Moscow Department of HealthA. Negovsky Research Institute of General Reanimatology; V. M. Buyanov State clinical hospital, Moscow Department of HealthV. M. Buyanov State clinical hospital, Moscow Department of HealthV. M. Buyanov State clinical hospital, Moscow Department of HealthA. Negovsky Research Institute of General ReanimatologyThe aim of the study was to determine the correlation between blood levels of Nterminal portion of the inactive precursor of natriuretic peptide of Btype (NTproBNP) and hemodynamic, clinical and laboratory parameters in the course of intensive treatment of patients with severe communityacquired pneumonia (CAP).Materials and methods. The study included 12 patients (10 men and 2 women) with severe CAP, age 25—88 (51.5 (41.25; 69)) years. The severity of the condition was as follows (averages and percentiles): on a scale of CURB65 — 3—5 (4; 4,5) scores, APACHE II — 16—33 (23 (18.75; 25)) scores, SOFA — 6—16 (10 (9; 12.75)) points. Concentartions of NTproBNP in venous blood 24—36 h post admission and on day 5 of treatment were determined by analyzer Dimension Xpand Plus (Siemens).Results. Within 24—36 hours after the admission concentration of NTproBNP was 783.5 (460.75; 4150.25) pg/ml. The content of the biomarker remained higher than in norm in 66.7% of patients. By the 5th day the concentration of the biomarker was 537 (376.25, 1334) pg/ml. In surviving patients (66.7%), the concentration of NT proBNP was decreasing (P=0.008) to day 5 of treatment from 918 (560, 8501) to 391 (341, 1010) pg/ml. CAP patients who did not survived later (32.3%) exhibited no decrease of the biomarker concentration. Significant correlation between NTproBNP on admission to ISU and index of total peripheral vascular resistance on day 2 of intensive treatment (r=0.63; p<0.05) and day 5 (r=0.58, P<0.05) was revealed. Echocardiography systolic pulmonary artery pressure correlated with the content of NTproBNP 24—36 hours after admission to the Intensive Care Unit and on the 5th day of treatment.Conclusion. We suggested that the reason for increased concentration of NTproBNP is an overload of the right ventricle myocardium due to pulmonary hypertension as a characteristic of acute respiratory distress syndrome.https://www.reanimatology.com/rmt/article/view/1527natriuretic peptide btypentprobnpcommunityacquired pneumoniapulmonary hypertensionacute respiratory distress syndrome
spellingShingle I. A. Kozlov
I. N. Tyurin
S. N. Avdeykin
I. Y. Ufimtseva
A. V. Salikov
N. A. Karpun
Biomarker NTproBNP in Patients with Severe CommunityAcquired Pneumonia
Общая реаниматология
natriuretic peptide btype
ntprobnp
communityacquired pneumonia
pulmonary hypertension
acute respiratory distress syndrome
title Biomarker NTproBNP in Patients with Severe CommunityAcquired Pneumonia
title_full Biomarker NTproBNP in Patients with Severe CommunityAcquired Pneumonia
title_fullStr Biomarker NTproBNP in Patients with Severe CommunityAcquired Pneumonia
title_full_unstemmed Biomarker NTproBNP in Patients with Severe CommunityAcquired Pneumonia
title_short Biomarker NTproBNP in Patients with Severe CommunityAcquired Pneumonia
title_sort biomarker ntprobnp in patients with severe communityacquired pneumonia
topic natriuretic peptide btype
ntprobnp
communityacquired pneumonia
pulmonary hypertension
acute respiratory distress syndrome
url https://www.reanimatology.com/rmt/article/view/1527
work_keys_str_mv AT iakozlov biomarkerntprobnpinpatientswithseverecommunityacquiredpneumonia
AT intyurin biomarkerntprobnpinpatientswithseverecommunityacquiredpneumonia
AT snavdeykin biomarkerntprobnpinpatientswithseverecommunityacquiredpneumonia
AT iyufimtseva biomarkerntprobnpinpatientswithseverecommunityacquiredpneumonia
AT avsalikov biomarkerntprobnpinpatientswithseverecommunityacquiredpneumonia
AT nakarpun biomarkerntprobnpinpatientswithseverecommunityacquiredpneumonia